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Penemuan asli I peningkatan pengetahuan 
The results of the present study show that 
1. Out of the three calcium channel blockers tested, administration of verapamil and flunarizine produced a 
significant decrease in the basal levels of:MDA in the brair) . 
2. Verapamil and fiunarizine also afforded protection against the anoxia-reoxygenation induced increase in MDA 
levels in brain 
3. In both the above veraparnil appeared to be more potent as compared to flunarizine. 
4. Diltiazem does not appear to share the neuroprotective which is evident in verapamil and flunarizine. 
These results provide a better understanding of the neuroprotective effects of calcium channel blockers. 
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K. MAKLUMAT LAIN YANG BERK.AITAN 
The results of the present study indicate that calcium channel blockers reduce anoxia-reoxygenation induced 
neuronal damage and give a comparative evaluation of three calcium channel blockers belonging to three different 
classes. However, in the present study we only pretreated the animals before anoxic challange. It would be 
interesting and perhaps more relevant clinically to see the effect of these agents when they are administered following 
the anoxic challange. Similarly. for the histological studies, we were unable to detect any changes in neuronal 
morphology using light microscopy. It would be worthwhile to see the changes in ultrastructure (using electron 
microscopy) in the acute phase following anoxia-reperfusion, and the effects os calcium channel blockers thereupon, 
if any. This study thus lays a foundation for further, more detailed exploration. 
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A Study on the Protective Effects of Calcium Channel Block~rs Against Anoxic 
Brain Damage 
Introduction 
It is now widely accepted that a rapid neuronal influx of Ca2+ following cerebral ischaemia! 
hypoxia is intimately connected with the cascade of events- including activation of enzymes which give 
rise to the production of reactive oxygen species and nitric oxide, thereby leading to free-radical induced 
damage -which reseult in neuronal injury and death. It is also known that a burst of free radical generation 
I 
occurs during re-oxygenation of the tissues following a period,ofischaernialhypoxia as also a prolonged 
purturbation of the membrane functions continues after the perfusion/oxygenation has been restored, which 
leads to continued accumulnnon of calcium intracellularly ; resulting ultimately in delayed damage and death 
of the neurone. 
Estimation of lipid peroxidation products proviqes a reliable estimate of free radical induced damage to 
tissues, and has been widely used for this purpose. 1 
Objectives 
The present study was undertaken with an aim to investigate whether : 
i)attempts to block the voltage dependent calcium channels with organic clacium channel blockers 
reduce the extent of free radical induced neuronal damage in the short term, following experimental global 
hypoxia4 in rats, as expressed by the presence of thiobarbituric acid reactive substances (TBARS) in· the 
brain tissue. 
ii)the expression of increased TBARS is also paralleled by any evidence of acute changes in 
neuronal morphology. 
Methods 
Adult rats ofWistar strain weighing betwee 150 lnd 200 gm were used for the present study. 
Each experimental group comprised of an equal number ofrats from either sex.Prior to experiments they 
were grouped in seaparte cages and fed standard rat pellet chow and water ad libitum. They were 
maintained under natural laght-dark cycle. All experimental procedures were done between 0930 and 1200 
and the biochemical estimations were completed within 4 hours of the sample collection. 
The following experimental groups were designed: 
Group 1. Control group (CON) 
Group 2. Untreated rats subjected to anoxia (ANOX) 
Group 3. Untreated rats subjected to anoxia followed by re-oxygenation (REO X) 
Groups 4- 6. Treated with either of the three calcium channel blockers (CCB), veraparnil 
(VerCON), diltiazem (Di!CON) or flunarizine (FluCON) 
Groups 7- 9. Subj'!cted to anoxia following pretreatment with veraparnil (VerANOX), diltiazem 
(DilANOX) or flunarizine (FiuANOX). 
Groups 10- 12. Subjected to anoxia andre-oxygenation following pretreatment with the three 
CCBs (VerREOX, DilREOX and FluREOX). 
Induction of anoxia and re-oxygenation: 
For induction of anoxia the rats were placed individually in one litre jars which were rendered airtight by 
putting a plasticine ring around their edges and then firmly placing a glass sheet over them to block air entry. 
The anin1als were allowed to breath in this closed space and were continuously observed for appearance of 
convulsions. In preliminary experiments it was determined that under these conditions the rats would 
develop convulsions after 30 minutes and would die shortly that if not allowed fresh air aftyer tllis stage. 
Since convulsions can by themselves cause widespread and unpredictable alterations in the brain 
biochemistry it was decided to subject the rats to anoxia for a period of 30 minutes. 
At the end of this period the animals were either sacrificed (anoxia groups) or replaced in their cages to 
allow them normal breathing environment for one hour (re-oxygenation group) prior to sacrifice. 
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. Decapitation and preparation of brain tissue: 
The rats were sacrificed by decapitation with a guillotine, just below the first cervical vertebra and The brain 
was quickly dissected out and put in ice cold nonnal saline (10 ml). For homogenization, the brain was taken 
out , ·dried with a blotting paper, weighrd and then homogenised in ice-cold trichloroacetic acid (TCA) to 
make a 10% homogenate. 
Histological studies 
For histology, fixation of the brain was done in 10% buffered formalin solution. After two weeks, coronal 
sections, passing through the hippocampus were cut The formalin fixed sections were dehydrated in 
ascending grades of alcoho~ cleared and paraffin embedded The paraffin embeded blocks were sectioned at 
4 micron and 10 micron thicknes with a rotatory microtome. Thick sections were stained with Nissl stain 
using cresyl violet. Myelin staining was done with luxol fast blue . Thin sections ·were stained with 
baematoxy1in and eosin stains. The sections were examined under Olympus microscope. 
Estimation of thobarbituric acid reactive substances (TBARs) in the brain homogenates : 
One m1 of the brain homogenate (10%), 1 ml of 40% TCA and 2 ml of 0.67% thiobarbituric acid 
solution were mixed, vortexed and incubated for 10 minutes in a boiling water (100 Celcius) bath. The 
reaction mixture was cooled, centrifuged and the colour intensity was measured with a spectrophotometer 
at a wavelength of 536 nm. The concentration of :MDA in terms of TBARs was calculated using the 
extinction coefficient of 1.56 X 10·5 M"J. 
Drug administration: 
All drugs were dissolved in distilled water and administered intraperitoneally in a volume not e~ceeding 0.2 
ml. The control group was administered 0.2 m1 of normal ssaline. In groups 4 - 6 drugs were administered 
60 min prior to decapitation while in groups 7- 12 they were administered 30 minutes prior to the anoxic 
challange. All the three drugs were administered in a dose of 5 mg per kg body weight. 
Treatment of data: 
The means and standard errors of the means (SEM) ofthe values of estimated MDA concentrations (nMol 
dL-1) for each group were computed and subjected to Student's 't' test for determining the level of 
significance of the differences between the means of different groups at an error level of 5%. 
Results and Conclusions 
I. Biochemical Studies: 
Data from a total of 120 rats were obtained and are reported below. Among the untreated groups the 
control, anoxia and re-oxyge:tation groups consisted of 24, 14 and 10 animals respectively while all the 
treated groups consisted of 8 animals each. The values for MDA levels are reported as mean ± s.e.m, in 
-t ' I ng.dL. 
Effect of anoxia and reoxygeoatioo on brain MDA levels in untreated rats (fig 1) 
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The mean MDA levels in the brains of rats which were allowed re-oxygenation following anoxia, were 
significantly higher as compared to that in the control group. However anoxia alone did not result in a 
---~----------------------.a----------------~--------------------~----~------------~----•. 
statistically significant alteration of the brain MDA levels. This observation is in ~greement with the reports 
which describe a burst of free radical generation during the epriod immediately following reperfusion of the 
hypoxic tissue. ! 
Effect of pretreatment with CCBs on the basal brain MDA content (Fig 2) 
l 
Effect of pretreatment with CCBs 
on basal levels of brain MDA 
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Pretreatment of rats with verapamil or flunarizine (5 mglkg i.p.) 60 minute prior to decapitation elicited a 
significant decrease in the basal levels ofbrain MDA content. Dose for dose, verapamil appeared more 
potent as compared to flunarizine ( mean "MDA levels 207.4 ±10.03 and 259.9 ± 16.17 ng/dL respectively, 
· p< O.Ol).ln contrast, pretreatment with diltiazem ( 5 mglkg, i.p.) did not produce any lowering of the basal 
brain MPA levels. Actually there appeared a tendency towards elevation of basal MDA levels, although this 
was not statistically significant. 
Effect of pretreatment with CCBs on the reoxygenation induced increase in brain MDA levels. 
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Effect of anoxia and reoxygenation 
in verapamil pretreated rats 
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In the verapamil pretreated group (Fig 3)~ anoxia followed by re-oxygenation did not produce ~y significant 
· alteration in the brain MDA conten~ indicating thereby that not only did verapaniil cause a decraese in the 
basal MDA content but it also prevented the anoxia-reoxygenation induced increase in free radical damage. 
Effect of anoxia and reoxygenatlon 
In ftunarlzlne pretreated rats 
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Although flunarizine pretreatment (Fig 4) produced relatively less decraese in basal MDA lt:vels as 
compared to verapamil~ yet like verapamil, it also inhibit¢ the anoxia-re-oxygenation induced increase in 
brain:MDA. 
The effects of diltiazem require a little more detailed analysis. In this group also, the MDA values following 
reoxygenation when compared with those in the diltiazem·treated-unchallanged rats were not found to be 
statistically different, implying thereby that diltiazem alaso affords protection against reoxygenation induced 
peroxidative damage. However, the basal :MDA values following diltiazem pretreatment (dilCON group) 
were higher than the control basal values, though not attaining statistically significant proportion with this 
sample size. Reoxygenation following diltiazem pretreatment also exhibits a trend towards increase in the 
mean MDA values however when compared against an already elevated basal value ( dilCON) it is not 
statistically significant. When we compare the post reoxygenation MDA values in all the four groups 
(REOX, VerREOX, FluREOX and DilREOX), the verapamil and flunarizine groups exhibit markedly 
lower MDA levels as compared to the control group while the :MD A values in the diltiazem treated group 
are statistically no different from the untreated-reoxygenation group (Fig 5). 
Re-oxygenatlon effects on brain MDA 
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Thus, while verapamil and flunarizine pre~ea~ents exlu'?it ~ lowe~ng of the basal MDA levels as well as a 
protective action asainBt anoxia .. regeneratlon tnduc'?d oxuiative bram damage expressed as TBARs, 
diltiazem does not appear to share 
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n. Histology studies: "· 
Light microscopic examination did not reveal any changes in the neurories subject~.d to anoxia or 
anoxia~reoxygenation. There was no neuronal loss or any degenerative changes such ~ hyoercbromatic 
nucleus, chromatolysis and shrinkage of perikaryon, microvacuolation in the mantle layer of the CAl, CA2, 
CA3 and CA4 regions of the hippocampus which was examined as this region is highly sensitive to anoxic 
stress. In the control and experimental groups, there was no morphological difference in the glial cells or in 
the neuropil. 
Neurons in the hippocamus which are sensitive to anoxia, and exhibit early changes induced by 
anoxia, do so within 24 to 72 hours following anoxia (Greenfield, 1992; Izumiyama, 1988; Sutherland, 
1988). In our study the animals were sacrificed within 60 - 90 min of the anoxic challange, it is possibl}{ too 
early for morphological chauges to become evident under light microscopy. However, changes at the 
ultrastructural or histochemical levels cannot be ruled out and need further conifrmation. 
